Peranan Supporting Psikis Tenaga Medis Terhadap Pengendalian Kecemasaan Pasien COVID-19 Yang Menjalani Isoman Di Rumah
Article Sidebar
-
COVID-19 , anxiety level, cure success rate
Abstract
A great influence on public health is caused by the COVID-19 pandemic, starting from the physical to the psychological community. When someone is confirmed to have COVID-19, anxiety about many things caused by this dangerous virus haunts everyone. Anxiety begins with a threatening situation as a dangerous stimulus. At a certain level, anxiety can make a person more alert to a threat, because if it is felt that the threat is considered harmless, then a person will not do self-defense. Anxiety needs to be managed properly so as not to cause excessive panic. Excessive anxiety will affect the body's immune system and affect the healing rate of COVID-19. The method used is an observational design with a cross-sectional design. This study is only to observe observational results using Zung's questionnaire on COVID-19 sufferers who are self-isolating at home.
References
Dekkers, O. M., Pereira, A. M., & Romijn, J. A. (2008). Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab, 93(10), 3717–3726.
Frank, G., Pasquini, E., Farneti, G., Mazzatenta, D., Sciarretta, V., Grasso, V., & Fustini, M. F. (2006). The endoscopic versus the traditional approach in pituitary surgery. Pubmed, 83(3–4), 240–248.
Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., Vance, M. L., & Society, E. (2011). Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 96(4), 894–904.
Gondim, J. A., Schops, M., Almeida, J. P. C. de, Albuquerque, L. A. F. de, Gomes, E., Ferraz, T., & Barroso, F. A. C. (2010). Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center. Pubmed, 13(1), 68–77.
Inder, W. J., & Hunt, P. J. (2002). Glucocorticoid replacement in pituitary surgery : guidelines for perioperative assesment and management. J Clin Endocrinol Metab, 87(6), 2745–2750.
Levy, A. (2004). Pituitary disease: presentation, diagnosis, and management. J Neurol Neurosurg Psychiatry, 75 (Suppl, 47–52.
Raverot, G., Assié, G., Cotton, F., Cogne, M., Boulin, A., Dherbomez, M., Bonneville, J. F., & Massart, C. (2015). Biological and radiological exploration and management of non-functioning pituitary adenoma. Ann Endocrinol (Paris), 76(3), 201–209.
Regan, J., & Watson, J. (2013). Selective use of peri-operative steroids in pituitary tumor surgery : escape from dogma. frontiers in endocrinology. Front Endocrinol (Lausanne), 4(30).
Tohti, M., Li, J., Zhou, Y., Hu, Y., Yu, Z., & Ma, C. (2015). Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis. PLoS ONE, 10(3).
Woodmansee, W. W., Carmichael, J., Kelly, D., Katznelson, L., & Committee, A. N. and P. S. (2015). American Association of Clinical Endocrinologistnand American College of Endocrinology Disease State Clinical Review: Postperative Management Following Pituitary Surgery. Endocr Pract, 21(7), 832–838.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.